Town & Country Bank & Trust CO dba First Bankers Trust CO raised its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 6.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,581 shares of the company’s stock after buying an additional 976 shares during the quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Zoetis were worth $2,539,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pensionfund Sabic grew its stake in Zoetis by 55.6% in the fourth quarter. Pensionfund Sabic now owns 11,200 shares of the company’s stock valued at $1,825,000 after acquiring an additional 4,000 shares during the period. PFW Advisors LLC bought a new position in shares of Zoetis in the 4th quarter valued at about $1,764,000. JPMorgan Chase & Co. increased its position in Zoetis by 10.6% during the third quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company’s stock worth $569,834,000 after buying an additional 279,092 shares during the last quarter. Simplify Asset Management Inc. bought a new stake in Zoetis in the 3rd quarter valued at $11,684,000. Finally, Nordea Investment Management AB raised its position in shares of Zoetis by 38.3% in the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after purchasing an additional 572,511 shares during the period. Institutional investors own 92.80% of the company’s stock.
Zoetis Stock Up 2.6 %
Shares of NYSE:ZTS opened at $173.07 on Tuesday. The business’s 50 day moving average is $170.10 and its 200 day moving average is $179.75. The stock has a market cap of $78.08 billion, a price-to-earnings ratio of 32.53, a PEG ratio of 2.57 and a beta of 0.89. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $200.53.
Zoetis Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. Zoetis’s payout ratio is currently 37.59%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on ZTS shares. UBS Group began coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target for the company. Stifel Nicolaus lowered their price target on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Leerink Partners assumed coverage on shares of Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, JPMorgan Chase & Co. raised their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $211.89.
Get Our Latest Stock Analysis on ZTS
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
See Also
- Five stocks we like better than Zoetis
- What Are Trending Stocks? Trending Stocks Explained
- 2 Stocks to Benefit From China Tariff Resets: Is 60% a Bluff?
- Best Stocks Under $10.00
- High-Yield Texas Instruments Poised to Rebound in 2025
- How to Read Stock Charts for Beginners
- NuScale Power Stock Leads Energy Gains – Can It Continue?
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.